← Back to Search

Vitamin D Supplement

Almond Milk with Vitamin D for Chronic Kidney Disease

N/A
Waitlist Available
Led By Jeanette Andrade, PhD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 21 days
Awards & highlights

Study Summary

This trial is testing whether D3 in micro- and nanoparticles is effective in enhancing vitamin D status and reducing inflammation markers.

Eligible Conditions
  • Chronic Kidney Failure
  • Chronic Kidney Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~21 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 21 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Vitamin D
Secondary outcome measures
C-reactive protein
Calcium
IL-6
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Based on estimated glomerular filtration rate (eGFR) and vitamin D levels, participants will be placed into the nanoparticle group.
Group II: ComparatorActive Control1 Intervention
Based on the estimated glomerular filtration rate (eGFR) and vitamin D levels, participants will be placed into the microparticle group.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
NanoD4CKD
2023
N/A
~30

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,340 Previous Clinical Trials
715,684 Total Patients Enrolled
Jeanette Andrade, PhDPrincipal InvestigatorUniversity of Florida

Media Library

MicroD4CKD (Vitamin D Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT05165173 — N/A
Chronic Kidney Failure Research Study Groups: Comparator, Intervention
Chronic Kidney Failure Clinical Trial 2023: MicroD4CKD Highlights & Side Effects. Trial Name: NCT05165173 — N/A
MicroD4CKD (Vitamin D Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05165173 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment in this clinical trial still open?

"This research initiative, which was initially listed on October 1st 2022, is no longer recruiting. However, there are currently 539 other medical trials that require new volunteers."

Answered by AI
~11 spots leftby Apr 2025